![Janet Hopkins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Janet Hopkins
Hoofd Techniek/Wetenschap/O&O bij
AURA BIOSCIENCES, INC.
Vermogen: 3 M $ op 31-08-2026
Profiel
Janet Jill Hopkins is Director at Gyroscope Therapeutics Holdings Plc since 2022 and Chief Medical Officer at Aura Biosciences, Inc. since 2023.
Former roles include Chief Executive Officer at Gyroscope Therapeutics Ltd. from 2021 to 2023 and SVP, Global Head-Ophthalmology & Exploratory at Novartis AG from 2021 to 2023.
Education includes a doctorate from McMaster University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,37% | 01-09-2026 | 380.190 ( 0,37% ) | 3 M $ | 31-08-2026 |
Actieve functies van Janet Hopkins
| Bedrijven | Functie | Begin |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Directeur/Bestuurslid | 17-02-2022 |
| AURA BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 16-10-2023 |
Eerdere bekende functies van Janet Hopkins
| Bedrijven | Functie | Einde |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01-10-2023 |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Algemeen Directeur | 01-10-2023 |
Opleiding van Janet Hopkins
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
55
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
McMaster University
 McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Health Technology |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
